Javascript is disabled or is not supported by your browser. Please upgrade your browser or enable Javascript to navigate the interface properly.

First Light Asset Management

Latest statistics and disclosures from First Light Asset Management's latest quarterly 13F-HR filing:

Top 5 stock holdings are NEO, SIBN, AXGN, APGE, PVLA, and represent 41.34% of First Light Asset Management's stock portfolio.
Added to shares of these 10 stocks: ELVN (+$59M), APGE (+$47M), SIBN (+$45M), TRVI (+$39M), NEO (+$37M), WGS (+$37M), TNDM (+$31M), GH (+$24M), TCMD (+$14M), PCVX (+$12M).
Started 2 new stock positions in TCMD, TRVI.
Reduced shares in these 10 stocks: Centessa Pharmaceuticals (-$62M), AXGN (-$58M), PVLA (-$32M), TWST (-$16M), WVE (-$13M), VERA (-$13M), MDXG (-$11M), SGP (-$9.7M), ORGO (-$8.3M), ESTA (-$5.2M).
Sold out of its positions in Centessa Pharmaceuticals, MDXG, ORGO, SGP, VERA, WVE.
First Light Asset Management was a net buyer of stock by $152M.
First Light Asset Management has $1.6B in assets under management (AUM), dropping by 47.44%.
Central Index Key (CIK): 0001600004

Tip: Access up to 7 years of quarterly data

Positions held by First Light Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csv

Download as Excel

Portfolio Holdings for First Light Asset Management

First Light Asset Management holds 31 positions in its portfolio as reported in the June 2026 quarterly 13F filing

Company (Ticker)	Portfolio Weight	Valued At	Change in Shares	Share Count	Share Price
Neogenomics Common Stocks (NEO)	10.9	$179M	+26%	12M	14.59	View chart
Si-bone Common Stocks (SIBN)	8.1	$133M	+51%	8.1M	16.32	View chart
Axogen Common Stocks (AXGN)	7.7	$127M	-31%	2.7M	46.19	View chart
Apogee Therapeutics Common Stocks (APGE)	7.5	$124M	+61%	930k	132.73	View chart
Palvella Therapeutics Common Stocks (PVLA)	7.2	$118M	-21%	772k	152.82	View chart
Twist Bioscience Corporation Common Stocks (TWST)	4.6	$75M	-17%	728k	102.88	View chart
Enliven Therapeutics Common Stocks (ELVN)	4.2	$69M	+574%	1.4M	50.75	View chart
Guardant Health Common Stocks (GH)	4.0	$66M	+57%	442k	150.03	View chart
908 Devices Common Stocks (MASS)	3.3	$55M	+3%	6.3M	8.70	View chart
Amylyx Pharmaceuticals Common Stocks (AMLX)	3.3	$54M	-5%	3.0M	17.96	View chart
Genedx Holdings Corp Common Stocks (WGS)	3.3	$54M	+222%	784k	68.65	View chart
Simulations Plus Common Stocks (SLP)	3.1	$51M	+6%	2.8M	18.31	View chart
Tandem Diabetes Care Common Stocks (TNDM)	3.1	$51M	+157%	3.4M	15.09	View chart
Crinetics Pharmaceuticals Common Stocks (CRNX)	3.1	$51M	+24%	1.4M	37.42	View chart
Neuropace Common Stocks (NPCE)	2.8	$46M	+16%	2.9M	15.89	View chart
Edgewise Therapeutics Common Stocks (EWTX)	2.7	$45M	+9%	1.1M	40.63	View chart
Anaptys Bio Common Stocks (ANAB)	2.4	$39M	+2%	582k	67.50	View chart
Trevi Therapeutics Common Stocks (TRVI)	2.4	$39M	NEW	2.1M	18.65	View chart
Septerna Common Stocks (SEPN)	2.0	$32M	+31%	963k	33.49	View chart
Trisalus Life Sciences Common Stocks (TLSI)	1.8	$30M	+29%	6.6M	4.55	View chart
Tectonic Therapeutics Common Stocks (TECX)	1.7	$28M	+23%	801k	34.38	View chart
Health Catalyst Common Stocks (HCAT)	1.5	$26M		13M	1.99	View chart
Butterfly Network Common Stocks (BFLY)	1.4	$22M		2.6M	8.42	View chart
Establishment Labs Holdings Common Stocks (ESTA)	1.3	$21M	-19%	247k	85.81	View chart
Vaxcyte Common Stocks (PCVX)	1.2	$20M	+143%	345k	58.13	View chart
Irhythm Technologies Common Stocks (IRTC)	1.2	$20M		167k	118.95	View chart
Omnicell Common Stocks (OMCL)	1.1	$19M	-7%	452k	41.52	View chart
Atricure Common Stocks (ATRC)	1.0	$16M	-22%	568k	27.98	View chart
Koru Medical Systems Common Stocks (KRMD)	0.9	$14M	-10%	3.4M	4.20	View chart
Tactile Systems Technology Common Stocks (TCMD)	0.8	$14M	NEW	463k	29.78	View chart
Rhythm Pharmaceuticals Common Stocks (RYTM)	0.6	$9.5M		86k	111.03	View chart

Past Filings by First Light Asset Management

SEC 13F filings are viewable for First Light Asset Management going back to 2013

First Light Asset Management 2026 Q2 filed Aug. 14, 2026
First Light Asset Management 2026 Q1 filed May 15, 2026
First Light Asset Management 2025 Q4 filed Feb. 17, 2026
First Light Asset Management 2025 Q3 filed Nov. 14, 2025
First Light Asset Management 2025 Q2 filed Aug. 14, 2025
First Light Asset Management 2025 Q1 filed May 15, 2025
First Light Asset Management 2024 Q4 filed Feb. 14, 2025
First Light Asset Management 2024 Q3 filed Nov. 14, 2024
First Light Asset Management 2024 Q2 filed Aug. 14, 2024
First Light Asset Management 2024 Q1 filed May 15, 2024
First Light Asset Management 2023 Q4 filed Feb. 14, 2024
First Light Asset Management 2023 Q3 filed Nov. 14, 2023
First Light Asset Management 2023 Q2 filed Aug. 14, 2023
First Light Asset Management 2023 Q1 filed May 15, 2023
First Light Asset Management 2022 Q4 filed Feb. 14, 2023
First Light Asset Management 2022 Q3 filed Nov. 14, 2022

View all past filings

Disclaimers: stockzoa.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on stockzoa.com represent a recommendation to purchase or sell a stock. The information on this site is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall stockzoa.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content available on stockzoa.com, or relating to the use of, or inability to use, stockzoa.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

Fund Directory: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X-Z